Financhill
Sell
32

PHAR Quote, Financials, Valuation and Earnings

Last price:
$16.53
Seasonality move :
-4.54%
Day range:
$15.79 - $16.60
52-week range:
$7.50 - $21.34
Dividend yield:
0%
P/E ratio:
1,144.76x
P/S ratio:
3.08x
P/B ratio:
4.24x
Volume:
23.5K
Avg. volume:
33.4K
1-year change:
79%
Market cap:
$1.1B
Revenue:
$296.7M
EPS (TTM):
$0.01

Earnings Data

Next earnings date for PHAR
Mar 12
2026
Most recent earnings per share
$0.11
Beat by $0.10
(Nov 6/2025)
Consensus Estimate
$0.00
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

PHAR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 $93.2M -- -- -- --
03/12/2026 Q4 $106.1M -- -- $0.01 --
11/06/2025 Q3 $91.2M $96.9M $0.11 $0.00 $0.10
07/31/2025 Q2 $82.5M $94.4M $0.07 -$0.01 $0.08
05/08/2025 Q1 $64.1M $79.2M -$0.22 -$0.03 -$0.19
03/13/2025 Q4 $80.6M $92M $0.05 $0.01 $0.05
10/24/2024 Q3 $76M $75.1M -$0.02 -$0.00 -$0.01
08/01/2024 Q2 $72M $74M -$0.02 -$0.00 -$0.02
05/08/2024 Q1 $69.9M $55.5M -$0.19 $0.01 -$0.19
03/14/2024 Q4 -- $81.9M -$0.04 $0.00 -$0.05
10/26/2023 Q3 -- $66.3M $0.05 -- --
08/03/2023 Q2 -- $54.8M $0.02 -- --
05/11/2023 Q1 -- $42.7M -$0.19 -- --
03/16/2023 Q4 -- $55.1M -$0.22 -- --
10/27/2022 Q3 -- $54M $0.13 -- --
08/04/2022 Q2 -- $49.8M $0.21 -- --
05/12/2022 Q1 -- $46.5M $0.05 -- --
03/17/2022 Q4 -- $52.6M $0.03 -- --
10/28/2021 Q3 -- $52.7M -$0.01 -- --
08/05/2021 Q2 -- $49.6M $0.09 -- --
05/13/2021 Q1 -- $43.4M $0.13 -- --
03/04/2021 Q4 -- $60.8M $0.14 -- --
09/30/2020 Q3 -- $53.9M $0.12 -- --
06/30/2020 Q2 -- $43.3M $0.15 -- --
03/31/2020 Q1 -- $54.3M $0.12 -- --
12/31/2019 Q4 -- $50.6M $0.20 -- --
09/30/2019 Q3 -- $50.5M $0.18 -- --
06/30/2019 Q2 -- $48M $0.12 -- --
03/31/2019 Q1 -- $40M $0.11 -- --
12/31/2018 Q4 -- $42M $0.19 -- --
09/30/2018 Q3 -- $45.2M $0.10 -- --
06/30/2018 Q2 -- $35.7M $0.06 -- --
03/31/2018 Q1 -- $36.2M $0.10 -- --
12/31/2017 Q4 -- $38.7M -$0.86 -- --
09/30/2017 Q3 -- $30.6M -$0.18 -- --
06/30/2017 Q2 -- $16.7M -$0.56 -- --
03/31/2017 Q1 -- $16.5M -$0.13 -- --
12/31/2016 Q4 -- $7.7M -$0.18 -- --
09/30/2016 Q3 -- $3.8M -$0.10 -- --
06/30/2016 Q2 -- $3.5M -$0.09 -- --
03/31/2016 Q1 -- $2.4M -$0.09 -- --

Pharming Group NV Earnings Questions

  • How Much did Pharming Group NV Generate in Revenue Last Quarter?

    Pharming Group NV reported $96.9M worth of top line sales in its most recent quarter.

  • Did Pharming Group NV Beat Earnings Last Quarter?

    Pharming Group NV announced earnings per share of $0.11 which represents a beat of analyst forecast a $0.00 per share.

  • Is Pharming Group NV Profitable?

    Pharming Group NV reported $89.8M that represents $1.31 per share over the last quarter.

  • What is the Analyst Consensus for Pharming Group NV EPS Next Year?

    Pharming Group NV's earnings are forecast to decrease from -$0.18 per share to $0.01 per share next year representing a decrease of -96.59%.

  • When is Pharming Group NV's Earnings Date?

    Pharming Group NV's next earnings date is March 12, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Sell
50
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 38x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Sell
37
Is GOOGL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 28x

Alerts

Buy
59
SEZL alert for Feb 27

Sezzle, Inc. [SEZL] is down 13.92% over the past day.

Buy
83
GCT alert for Feb 27

GigaCloud Technology, Inc. [GCT] is down 5.87% over the past day.

Buy
62
LMAT alert for Feb 27

LeMaitre Vascular, Inc. [LMAT] is down 4.76% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock